This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
Lumos Pharma, Inc.
Q42022
3/1/2023
Operator
Conference Operator
Good afternoon and welcome to Loomis Pharma's 2022 Financial Results Conference Call.
Operator
Conference Operator
Currently, all participants are in a listen-only mode.
Operator
Conference Operator
We will conduct a question and answer session. We'll follow at that time. As a reminder, this conference call is being recorded. We'll now turn the call over to Lisa Miller, Senior Director of Investor Relations. Ma'am, please go ahead.
You're reading a preview of the LUMO Q4 2022 earnings call.
Free account.
Disclaimer